This week the Government revealed its Spending Review - we dive into what the settlement means for progress on dementia.

Prof Sir John Hardy, Vice President of Alzheimer’s Research UK, outlines how the UK can continue to drive progress towards a ...

There’s been a leap in potential new medicines being tested in clinical trials for Alzheimer’s, according to a new annual ...

Early and accurate diagnosis is the cornerstone of effective, person-centred care – and nowhere is this more important than in dementia. Spotting the signs early and getting a diagnosis can change ...

Blood tests could soon revolutionise the way that dementia is diagnosed. They are faster, cheaper and as accurate as other diagnostic tests (“biomarkers”) of Alzheimer’s that are currently in use.

“If the clinical trials I’ve taken part in help people in the future, then I’m glad I took part,” says Alzheimer’s Research UK supporter Marian Wheeler. When Marian was diagnosed with Alzheimer’s ...

A new study published today in BMJ suggests that the herpes simplex virus type 1 could have a role in the development of Alzheimer’s disease. Herpes simplex virus type 1, also known as HSV-1, is a ...

People with early-stage Alzheimer’s disease in Scotland will not be able to access the drug donanemab on the NHS, after it was rejected for use by the Scottish Medicines Consortium (SMC). Donanemab is ...

Our Research Conference is an opportunity to celebrate excellence from researchers at all stages of their careers. The day before our Research Conference, we’re holding a day designed for early career ...

Right now, there isn’t a cure for people with dementia. But hope is on the horizon with lecanemab and donanemab – the first Alzheimer’s treatments licensed in Britain that can slow down the disease, ...

Dementia devastates the lives of everyone it touches, but our analysis shows that women are bearing a disproportionate weight of the impact. Our analysis shows that dementia became the leading cause ...

Dementia disrupts lives. We hope our campaigns do too. Working with award-winning filmmakers and global celebrity supporters, our campaigns are intended to disrupt the fatalism around dementia, ...